Iconix Signs Chemogenomics Agreement with Taisho | GenomeWeb

NEW YORK, June 15 (GenomeWeb News) - Iconix Pharmaceuticals will perform chemogenomics profiling and analysis services for Taisho Pharmaceutical of Japan, Mountain View, Calif.-based Iconix said today.

 

Under the agreement, Taisho will apply Iconix's DrugMatrix platform, a chemogenomics database, to help it select and optimize drug candidates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.